Maravai LifeSciences Holdings Inc Share Price Today: Live Updates & Key Insights

Maravai LifeSciences Holdings Inc share price today is $2.98, up -1.65%. The stock opened at $3.05 against the previous close of $3.03, with an intraday high of $3.075 and low of $2.95.

Maravai LifeSciences Holdings Inc Share Price Chart

Maravai LifeSciences Holdings Inc

us-stock
To Invest in {{usstockname}}
us-stock

Maravai LifeSciences Holdings Inc Share Price Performance

$2.98 -0.0165(-1.65%) MRVI at 23 Mar 2026 02:20 PM Biotechnology
Lowest Today 2.95
Highest Today 3.075
Today’s Open 3.05
Prev. Close 3.03
52 Week High 4.11
52 Week Low 1.67
Day’s Range: Low 2.95 High 3.075
52-Week Range: Low 1.67 High 4.11
1 day return -
1 Week return -4.77
1 month return -2.44
3 month return -14.44
6 month return +8.33
1 year return +33.18
3 year return -78.07
5 year return -91.91
10 year return -

Maravai LifeSciences Holdings Inc Institutional Holdings

GTCR LLC 13.77

BlackRock Inc 6.22

12 West Capital Management LP 6.09

BRAIDWELL LP 5.71

Vanguard Group Inc 4.90

T. Rowe Price Investment Management,Inc. 4.21

Mackenzie Investments 4.15

Canada Life US Small-Mid Cap Growth F 3.12

Renaissance Technologies Corp 2.89

Vanguard Total Stock Mkt Idx Inv 2.68

Mirabella Financial Services LLP 2.56

Monaco Asset Management 2.50

Philosophy Capital Management LLC 2.12

Morgan Stanley - Brokerage Accounts 1.97

Geode Capital Management, LLC 1.95

iShares Russell 2000 ETF 1.85

Point72 (DIFC) Ltd 1.77

Tejara Capital Ltd 1.68

UBS Group AG 1.64

State Street Corp 1.63

Wellington Management Company LLP 1.61

T. Rowe Price US Small-Cap Core Equity 1.48

Marshall Wace Asset Management Ltd 1.37

Deutsche Bank AG 1.29

First Eagle Small Cap Opportunity I 1.27

T. Rowe Price Small-Cap Stock 1.21

First Eagle US Small Cap Strategy 1.08

Vanguard Institutional Extnd Mkt Idx Tr 0.92

Fidelity Small Cap Index 0.73

Royce Micro-Cap Trust 0.72

T. Rowe Price Small-Cap Value 0.68

T. Rowe Price U.S. SC Core Eq Tr-D 0.67

iShares Russell 2000 Value ETF 0.66

T. Rowe Price Instl Small-Cap Stock 0.64

iShares Biotechnology ETF 0.54

IG Mackenzie U.S. Small-Mid Cap Growth C 0.47

T. Rowe Price U.S. SC Value Eq Tr-D 0.46

Fidelity Extended Market Index 0.45

State St Russell Sm/Mid Cp® Indx SL Cl I 0.44

Xtrackers S&P 500 Swap ETF 1C 0.43

Maravai LifeSciences Holdings Inc Market Status

Strong Buy: 5

Buy: 1

Hold: 7

Sell: 0

Strong Sell: 0

Maravai LifeSciences Holdings Inc Fundamentals

Market Cap 1095.90 M

PB Ratio 2.054

PE Ratio 0.0

Enterprise Value 591.36 M

Total Assets 770.58 M

Volume 2831356

Maravai LifeSciences Holdings Inc Company Financials

Annual Revenue FY25:49866000 49.9M, FY23:419517000 419.5M, FY22:883001000 883.0M, FY21:799240000 799.2M, FY20:284098000 284.1M

Annual Profit FY25:12842000 12.8M, FY23:252629000 252.6M, FY22:714044000 714.0M, FY21:658679000 658.7M, FY20:204449000 204.4M

Annual Net worth FY25:-203428000 -203.4M, FY23:24564000 24.6M, FY22:490663000 490.7M, FY21:469250000 469.3M, FY20:88972000 89.0M

Quarterly Revenue Q4/2025:49866000 49.9M, Q3/2025:41630000 41.6M, Q2/2025:47397000 47.4M, Q1/2025:46850000 46.9M, Q3/2024:65200000 65.2M

Quarterly Profit Q4/2025:12842000 12.8M, Q3/2025:5655000 5.7M, Q2/2025:7768000 7.8M, Q1/2025:7725000 7.7M, Q3/2024:28374000 28.4M

Quarterly Net worth Q4/2025:-35681000 -35.7M, Q3/2025:-25556000 -25.6M, Q2/2025:-39591000 -39.6M, Q1/2025:-29945000 -29.9M, Q3/2024:-99038000 -99.0M

About Maravai LifeSciences Holdings Inc & investment objective

Company Information Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS. The TRILINK segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, CleanCap capping technology-based oligonucleotide building blocks, and custom enzyme development and manufacturing; and research products for labeling and detecting proteins in cells and tissue samples. The CYGNUS segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, and antibody-based products to detect impurities during the production of biopharmaceutical products. It serves biopharmaceutical companies, and emerging biopharmaceutical and life sciences research companies; and academic research institutions and diagnostics companies. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California.

Organisation Biotechnology

Employees 435

Industry Biotechnology

CEO Mr. Bernd Brust

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Maravai LifeSciences Holdings Inc FAQs

What is the share price of Maravai LifeSciences Holdings Inc today?

The current share price of Maravai LifeSciences Holdings Inc is $2.98.

Can I buy Maravai LifeSciences Holdings Inc shares in India?

Yes, Indian investors can buy Maravai LifeSciences Holdings Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Maravai LifeSciences Holdings Inc shares in India?

You can easily invest in Maravai LifeSciences Holdings Inc shares from India by:

Can I buy fractional shares of Maravai LifeSciences Holdings Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Maravai LifeSciences Holdings Inc?

Maravai LifeSciences Holdings Inc has a market cap of $1095.90 M.

In which sector does Maravai LifeSciences Holdings Inc belong?

Maravai LifeSciences Holdings Inc operates in the Biotechnology sector.

What documents are required to invest in Maravai LifeSciences Holdings Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Maravai LifeSciences Holdings Inc?

The PE ratio of Maravai LifeSciences Holdings Inc is N/A and the PB ratio is 2.05.